MD Anderson and nation’s top cancer centers partner to endorse goal of eliminating HPV-related cancers
Jun 07, 2018 | 459 views | 0 0 comments | 1 1 recommendations | email to a friend | print
MD Anderson and nation’s top cancer centers partner to endorse goal of eliminating HPV-related cancers
Joint statement encourages parents, young adults and physicians to take advantage of vaccination to prevent future HPV-related cancers
Contact: Clayton R. Boldt Office: 713-792-9518 Cell: crboldt@mdanderson.org  
Contact: Allison Schaffer Office: 713-745-1357 Cell: aschaffer@mdanderson.org
SHARE THIS: Share this email with your network on facebook Share this email with your network on twitter Forward this to a friend

HOUSTON ― Recognizing that vaccination rates for the human papillomavirus (HPV) remain low across the U.S., particularly in Texas, The University of Texas 

MD Anderson Cancer Center
 again has joined with the 69 other National Cancer Institute (NCI)-designated cancer centers in issuing a joint statement to call for increased HPV vaccination and evidence-based screening, with the goal of eliminating cancers caused by the virus.

This is the third national call to action from NCI-designated cancer centers, with the first statement published in 2016. All 70 cancer centers, representing the nation’s leaders in cancer care and research, perceive low vaccination rates as a public health threat and call upon physicians, parents and young adults to take advantage of this opportunity to prevent several types of cancer in men and women.

For the first time, the statement also is endorsed by American Cancer Society, the American Association for Cancer Research, the American Society for Clinical Oncology, the Prevent Cancer Foundation, the American Society for Preventive Oncology and the Association of American Cancer Institutes.

Ernest Hawk, M.D.
Ernest Hawk, M.D.

“MD Anderson fully supports this joint effort to encourage evidence-based practices that can make a significant impact on the rising numbers of HPV-related cancers we diagnose and treat each year,” said Ernest Hawk, M.D., vice president and division head, Cancer Prevention and Population Sciences. “By increasing HPV vaccination and recommended cancer screening, we can make tremendous progress toward actually eliminating HPV-related cancers within our lifetimes, beginning with cervical cancer.” 

HPV, a group of more than 150 viruses, is responsible for the majority of cervical, anal, oropharyngeal (middle) throat and other genital cancers. The Centers for Disease Control and Prevention (CDC) report that incidence rates of HPV-related cancers continue to increase, with an estimated 41,000 new cases diagnosed each year in the U.S.

Proven methods are available to screen for and treat cervical pre-cancers, and research suggests the HPV vaccine is safe and effective in preventing most cancers caused by HPV. Currently, the CDC recommends all children complete a two-dose vaccine series at age 11 or 12. The vaccine is recommended for young men up to age 21 and young women up to age 26, though adolescents older than 14 years will need to complete a three-dose vaccine series.

However, just 49.5 percent of girls and 37.5 percent of boys across the U.S. have completed the recommended vaccine series, according to a 2016 CDC report. In Texas, vaccination rates are even lower, with only 39.7 percent of girls and 26.5 percent of boys completing the appropriate vaccine series. These rates fall far short of the national goal of 80 percent, set by the U.S. Department of Health and Human Services’ Healthy People 2020 Initiative.

Lois Ramondetta, M.D.
Lois Ramondetta, M.D.

HPV experts from the nation’s top cancer centers, along with partners from the NCI, CDC, and the ACS, are meeting June 7-8in Salt Lake City to discuss a path forward to eliminating cancers caused by HPV, including ways to reduce barriers to vaccination as well as share education, training and intervention strategies to improve vaccination and screening rates. 

“Too many people needlessly suffer from HPV-related pre-cancers and cancers each year, while we have safe and effective ways to prevent this,” said Lois Ramondetta, M.D., professor of Gynecologic Oncology and Reproductive Medicine. “We encourage physicians to strongly and consistently advocate for vaccination and screening in their patients, and for parents to strongly advocate vaccination for their children, all to protect against future cancers caused by HPV.” 

 - 30 -

About MD Anderson

The University of Texas MD Anderson Cancer Center in Houston ranks as one of the world's most respected centers focused on cancer patient care, research, education and prevention. The institution's sole mission is to end cancer for patients and their families around the world. MD Anderson is one of only 49 comprehensive cancer centers designated by the National Cancer Institute (NCI). MD Anderson is ranked No. 1 for cancer care in U.S. News & World Report's Best Hospitals survey. It has ranked as one of the nation's top two hospitals for cancer care since the survey began in 1990, and has ranked first 13 times in the last 16 years. MD Anderson receives a cancer center support grant from the NCI of the National Institutes of Health (P30 CA016672).



Facebook Twitter Google+ Pinterest RSS YouTube iTunes U

© 2018 The University of Texas MD Anderson Cancer Center

Comments
(0)
Comments-icon Post a Comment
No Comments Yet